MS has copped some criticism and I for one have given some over time with what I’ve thought was warranted, however, in the last 12 months the communication from this company has been nothing short of excellent. A lot of the communication was done under high scrutiny from the ASX and the company has navigated an exciting yet difficult period with aplomb. MS has been a huge part of that.
It’s very apparent that a board restructure is taking place as the company transforms and this in my mind is expected. This is a forward and positive move as we move to being the next Qiagen(US$12B market cap) of the Biopharmaceutical industry.
Well done MS, good luck with your future endeavours, smile and wave
